Leukemia : official journal of the Leukemia Society of America, Leukemia Research Fund, U.K, 1476-5551

Journal

More filtering options
  1. 2019
  2. Genetic predisposition to B-cell acute lymphoblastic leukemia at 14q11.2 is mediated by a CEBPE promoter polymorphism

    Studd, J. B., Minjun Yang, Li, Z., Vijayakrishnan, J., Lu, Y., Yeoh, A. E. J., Kajsa Paulsson & Houlston, R. S., 2019 Jan, In : Leukemia. 33, 1, p. 1-14

    Research output: Contribution to journalArticle

  3. Exome sequencing identifies germline variants in DIS3 in familial multiple myeloma

    Maroulio Pertesi, Björn Nilsson, McKay, J. D., Dumontet, C. & et al., 2019, In : Leukemia.

    Research output: Contribution to journalLetter

  4. FLT3 N676K drives acute myeloid leukemia in a xenograft model of KMT2A-MLLT3 leukemogenesis

    Axel Hyrenius-Wittsten, Mattias Pilheden, Falqués-Costa, A., Eriksson, M., Sturesson, H., Schneider, P., Wander, P., Garcia-Ruiz, C., Liu, J., Helena Ågerstam, Anne Hultquist, Lilljebjörn, H., Stam, R. W., Marcus Järås & Anna K. Hagström-Andersson, 2019, In : Leukemia.

    Research output: Contribution to journalLetter

  5. Genome-wide association study of monoclonal gammopathy of unknown significance (MGUS): comparison with multiple myeloma

    Hauke Thomsen, Chattopadhyay, S., Weinhold, N., Vodicka, P., Vodickova, L., Hoffmann, P., Nöthen, M. M., Jöckel, K. H., Langer, C., Hajek, R., Hallmans, G., Pettersson-Kymmer, U., Ohlsson, C., Späth, F., Houlston, R., Goldschmidt, H., Kari Hemminki & Asta Försti, 2019, In : Leukemia : official journal of the Leukemia Society of America, Leukemia Research Fund, U.K. 5 p.

    Research output: Contribution to journalLetter

  6. 2018
  7. Late mortality after allogeneic blood or marrow transplantation in childhood for leukemia: a report from the Blood or Marrow Transplant Survivor Study-2

    Anna Sällfors Holmqvist, Chen, Y., Wu, J., Kung, M., Ness, E., Parman, M., Francisco, L., Hageman, L., Battles, K., Bhatia, R., Salzman, D., Winther, J. F., Rosenthal, J., Forman, S. J., Weisdorf, D. J., Armenian, S. H., Arora, M. & Bhatia, S., 2018 Dec, In : Leukemia. 32, 12, p. 2706-2709

    Research output: Contribution to journalArticle

  8. Whole-exome sequencing exploration of acquired uniparental disomies in B-cell precursor acute lymphoblastic leukemia

    Kristina B. Lundin-Ström, Biloglav, A., Lilljebjörn, H., Rissler, M., Thoas Fioretos, Markus Hansson, Behrendtz, M., Anders Castor, Linda Olsson & Bertil Johansson, 2018 Sep, In : Leukemia. 32, 9, p. 2058-2062

    Research output: Contribution to journalArticle

  9. Ibrutinib versus temsirolimus: 3-year follow-up of patients with previously treated mantle cell lymphoma from the phase 3, international, randomized, open-label RAY study

    Rule, S., Jurczak, W., M. Jerkeman, Rusconi, C., Trneny, M., Offner, F., Caballero, D., Joao, C., Witzens-Harig, M., Hess, G., Bence-Bruckler, I., Cho, S. G., Thieblemont, C., Zhou, W., Henninger, T., Goldberg, J., Vermeulen, J. & Dreyling, M., 2018 Aug, In : Leukemia. 32, 8, p. 1799-1803

    Research output: Contribution to journalArticle

  10. SAMD9 and SAMD9L in inherited predisposition to ataxia, pancytopenia, and myeloid malignancies

    Josef Davidsson, Andreas Puschmann, Ulf Tedgård, David Bryder, Nilsson, L. & Cammenga, J., 2018 May, In : Leukemia. 32, 5, p. 1106-1115

    Research output: Contribution to journalArticle

  11. Mutation, methylation, and gene expression profiles in dup(1q)-positive pediatric B-cell precursor acute lymphoblastic leukemia

    Rebeqa Gunnarsson, Dilorenzo, S., Kristina B. Lundin-Ström, Linda Olsson, Biloglav, A., Lilljebjörn, H., Rissler, M., Wahlberg, P., Lundmark, A., Anders Castor, Behrendtz, M., Thoas Fioretos, Kajsa Paulsson, Isaksson, A. & Bertil Johansson, 2018, In : Leukemia. 32, 10, p. 2117-2125

    Research output: Contribution to journalArticle

  12. 2017
  13. Genome-wide association study of immunoglobulin light chain amyloidosis in three patient cohorts: Comparison with myeloma

    Da Silva Filho, M. I., Försti, A., Weinhold, N., Meziane, I., Campo, C., Huhn, S., Nickel, J., Hoffmann, P., Nöthen, M. M., Jöckel, K. H., Landi, S., Mitchell, J. S., Johnson, D., Morgan, G. J., Houlston, R., Goldschmidt, H., Jauch, A., Milani, P., Merlini, G., Rowcieno, D. & 6 othersHawkins, P., Hegenbart, U., Palladini, G., Wechalekar, A., Schönland, S. O. & K. Hemminki, 2017 Aug 1, In : Leukemia. 31, 8, p. 1735-1742 8 p.

    Research output: Contribution to journalArticle

  14. No increased prevalence of malignancies among first-degree relatives of 800 patients with chronic myeloid leukemia: A population-based study in Sweden

    Gunnarsson, N., Höglund, M., Stenke, L., Sandin, F., Björkholm, M., Dreimane, A., Lambe, M., Markevärn, B., Olsson-Strömberg, U., Wadenvik, H., J. Richter & Själander, A., 2017 Aug 1, In : Leukemia. 31, 8, p. 1825-1827 3 p.

    Research output: Contribution to journalLetter

  15. Early death rates remain high in high-risk APL: Update from the Swedish Acute Leukemia Registry 1997-2013

    Lehmann, S., Deneberg, S., Antunovic, P., Rangert-Derolf, Garelius, H., Lazarevic, V., Myhr-Eriksson, K., Möllgård, L., Uggla, B., Wahlin, A., Wennström, L., Höglund, M. & G. Juliusson, 2017 Jun 1, In : Leukemia. 31, 6, p. 1457-1459

    Research output: Contribution to journalLetter

  16. Increased proportion of mature NK cells is associated with successful imatinib discontinuation in chronic myeloid leukemia

    Ilander, M., Olsson-Strömberg, U., Schlums, H., Guilhot, J., Brück, O., Lähteenmäki, H., Kasanen, T., Koskenvesa, P., Söderlund, S., Höglund, M., Markevärn, B., Själander, A., Lotfi, K., Dreimane, A., Lübking, A., Holm, E., Björeman, M., Lehmann, S., Stenke, L., Ohm, L. & 11 othersGedde-Dahl, T., Majeed, W., H. Ehrencrona, Koskela, S., Saussele, S., Mahon, F. X., Porkka, K., Hjorth-Hansen, H., Bryceson, Y. T., J. Richter & Mustjoki, S., 2017 May 1, In : Leukemia. 31, 5, p. 1108-1116 9 p.

    Research output: Contribution to journalArticle

  17. A genome-wide association study identifies risk loci for childhood acute lymphoblastic leukemia at 10q26.13 and 12q23.1

    Vijayakrishnan, J., Kumar, R., Henrion, M. Y. R., Moorman, A. V., Rachakonda, P. S., Hosen, I., Da Silva Filho, M. I., Holroyd, A., Dobbins, S. E., Koehler, R., Thomsen, H., Irving, J. A., Allan, J. M., Lightfoot, T., Roman, E., Kinsey, S. E., Sheridan, E., Thompson, P. D., Hoffmann, P., Nöthen, M. M. & 9 othersHeilmann-Heimbach, S., Jöckel, K-H., Greaves, M. W., Harrison, C. J., Bartram, C. R., Schrappe, M., Stanulla, M., K. Hemminki & Houlston, R. S., 2017 Mar 1, In : Leukemia. 31, 3, p. 573-579 7 p.

    Research output: Contribution to journalArticle

  18. Prevalence and characteristics of survivors from acute myeloid leukemia in Sweden

    G. Juliusson, Abrahamsson, J., Lazarevic, V., Antunovic, P., Derolf, Garelius, H., Lehmann, S., Myhr-Eriksson, K., Möllgård, L., Uggla, B., Wahlin, A., Wennström, L. & Höglund, M., 2017 Mar 1, In : Leukemia. 31, 3, p. 728-731 4 p.

    Research output: Contribution to journalLetter

  19. Induction of the 5S RNP–Mdm2–p53 ribosomal stress pathway delays the initiation but fails to eradicate established murine acute myeloid leukemia

    Jaako, P., A. Ugale, M. Wahlestedt, Velasco, T., Cammenga, J., Lindström, M. S. & D. Bryder, 2017 Jan, In : Leukemia. 31, 1, p. 213-221

    Research output: Contribution to journalArticle

  20. Natural history of relapsed myeloma, refractory to immunomodulatory drugs and proteasome inhibitors: a multicenter IMWG study

    Dimopoulos, M. A., Kastritis, E., Terpos, E., Nahi, H., Goldschmidt, H., Hillengass, J., Leleu, X., Beksac, M., Alsina, M., Oriol, A., Cavo, M., Ocio, E. M., Mateos, M. V., O'Donnell, E. K., Vij, R., Lokhorst, H. M., van de Donk, N. W. C. J., Cam-min, J., Mark, T., Turesson, I. & 21 othersMarkus Hansson, Jagannath, S., Delforge, M., Kyriakou, C., Hari, P., Mellqvist, U. H., Usmani, S. Z., Dytfeld, D., Badros, A. Z., Otero, P. R., Shustik, C., Waller, D., Chng, W-J., Ozaki, S., de la Rubia, J., Eom, H. S., Rosinol, L., Lahuerta, J. J., Sureda, A., Kim, J. S. & Durie, B. G. M., 2017, In : Leukemia. 31, p. 2443-2448

    Research output: Contribution to journalArticle

  21. 2016
  22. High rate of recurrent venous thromboembolism in patients with myeloproliferative neoplasms and effect of prophylaxis with Vitamin K antagonists

    De Stefano, V., Ruggeri, M., Cervantes, F., Alvarez-Larran, A., Iurlo, A., Randi, M. L., Elli, E., Finazzi, M. C., Finazzi, G., Zetterberg, E., Vianelli, N., Gaidano, G., Rossi, E., Betti, S., Nichele, I., Cattaneo, D., Palova, M., Ellis, M. H., Cacciola, R., Tieghi, A. & 11 othersHernandez-Boluda, J. C., Pungolino, E., Specchia, G., Rapezzi, D., Forcina, A., Musolino, C., Carobbio, A., Griesshammer, M., Sant'Antonio, E., Vannucchi, A. M. & Barbui, T., 2016 Oct 1, In : Leukemia. 30, 10, p. 2032-2038 7 p.

    Research output: Contribution to journalArticle

  23. Safety and efficacy of the combination of pegylated interferon-α2b and dasatinib in newly diagnosed chronic-phase chronic myeloid leukemia patients

    Hjorth-Hansen, H., Stentoft, J., Richter, J., Koskenvesa, P., Höglund, M., Dreimane, A., Porkka, K., Gedde-Dahl, T., Gjertsen, B. T., Gruber, F. X., Stenke, L., Eriksson, K. M., Markevärn, B., Lübking, A., Vestergaard, H., Udby, L., Bjerrum, O. W., Persson, I., Mustjoki, S. & Olsson-Strömberg, U., 2016 Sep 1, In : Leukemia. 30, 9, p. 1853-1860 8 p.

    Research output: Contribution to journalArticle

  24. The concept of treatment-free remission in chronic myeloid leukemia

    Saußele, S., J. Richter, Hochhaus, A. & Mahon, F. X., 2016 Aug 1, In : Leukemia. 30, 8, p. 1638-1647 10 p.

    Research output: Contribution to journalReview article

  25. Increased prevalence of prior malignancies and autoimmune diseases in patients diagnosed with chronic myeloid leukemia

    Gunnarsson, N., Höglund, M., Stenke, L., Wallberg-Jonsson, S., Sandin, F., Björkholm, M., Dreimane, A., Lambe, M., Markevärn, B., Olsson-Strömberg, U., Wadenvik, H., J. Richter & Själander, A., 2016 Jul 1, In : Leukemia. 30, 7, p. 1562-1567 6 p.

    Research output: Contribution to journalArticle

  26. Familial associations of monoclonal gammopathy of unknown significance with autoimmune diseases

    K Hemminki, A Försti, K Sundquist, J Sundquist & Li, X., 2016, In : Leukemia. 30, p. 1766–1769

    Research output: Contribution to journalLetter

  27. Familial risk of non-Hodgkin lymphoma by sex, relationship, age at diagnosis and histology: a joint study from five Nordic countries.

    Fallah, M., Kharazmi, E., Pukkala, E., Tretli, S., Olsen, J. H., Tryggvadottir, L., Kristina Sundquist & Kari Hemminki, 2016, In : Leukemia. 30, p. 373-378

    Research output: Contribution to journalArticle

  28. Genetic factors influencing the risk of multiple myeloma bone disease.

    Johnson, D. C., Weinhold, N., Mitchell, J., Chen, B., Stephens, O. W., Försti, A., Nickel, J., Kaiser, M., Gregory, W. A., Cairns, D., Jackson, G. H., Hoffmann, P., Noethen, M. M., Hillengass, J., Bertsch, U., Barlogie, B., Davis, F. E., Hemminki, K., Goldschmidt, H., Houlston, R. S. & 1 othersMorgan, G. J., 2016, In : Leukemia. 30, p. 883-888

    Research output: Contribution to journalArticle

Previous 1 2 3 4 5 6 Next